Cardiff Lexington Subsidiary Nova Ortho and Spine Performs First Procedures at Doctor's Memorial Hospital in Perry, Florida

Rhea-AI Summary

Cardiff Lexington (OTCQB:CDIX) announced that its subsidiary Nova Ortho and Spine performed first procedures on December 11, 2025 at Doctor's Memorial Hospital in Perry, Florida.

The move targets Taylor County, described as severely underserved with poor health outcomes and a high provider-to-patient ratio; Cardiff Lexington said the visit brings pain management, orthopedic, and spine surgical services to the local community and signals intent to expand into additional rural Florida areas.

News Market Reaction

-1.20%

1 alert

-1.20% News Effect

On the day this news was published, CDIX declined 1.20%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Q3 2025 revenue: $3,058,740 Q3 2024 revenue: $1,355,641 Q3 2025 net loss: $1,144,299 +5 more

8 metrics

Q3 2025 revenue $3,058,740 Quarter ended September 30, 2025

Q3 2024 revenue $1,355,641 Prior-year quarter for comparison

Q3 2025 net loss $1,144,299 Driven by interest expense of $1,765,528

Nine-month 2025 revenue $8,763,314 Nine months ended September 30, 2025

Nine-month 2025 net loss $2,821,471 Cumulative loss for nine months 2025

Cash balance $232,033 As of September 30, 2025

Accounts receivable $20,699,999 Healthcare receivables at 42% realization rate

Reverse split range 1-for-2 to 1-for-6 Board-authorized window through March 31, 2026

Market Reality Check

Price: $1.30 Vol: Pre-news volume 6,382 vs ...

high vol

$1.30 Last Close

Volume Pre-news volume 6,382 vs 20-day average 3,557 (relative volume 1.79x). high

Technical Shares at $1.75, trading below 200-day MA of $5.17 and 98.33% under 52-week high.

Peers on Argus

CDIX showed a pre-news gain of 14.9% while close peers were mixed, with moves fr...

CDIX showed a pre-news gain of 14.9% while close peers were mixed, with moves from -9.09% (GBCS) to +19.05% (VLXC), suggesting company-specific dynamics rather than a broad sector trend.

Historical Context

2 past events · Latest: Nov 07 (Neutral)

Pattern 2 events

Date	Event	Sentiment	Move	Catalyst
Nov 07	Earnings call scheduling	Neutral	+0.0%	Announced Q3 2025 earnings release date and investor conference call logistics.
Aug 12	Earnings postponement	Negative	-25.0%	Postponed Q2 2025 earnings release and call without a new announced date.

Pattern Detected

Limited history shows price reactions generally aligning with news tone, including a sharp selloff on negative earnings timing news.

Recent Company History

Recent disclosures highlighted both operational and capital-structure stress. A 10-Q on November 12, 2025 showed strong revenue growth but ongoing net losses and going-concern language. A DEF 14C on December 1, 2025 outlined flexibility for a reverse stock split between 1-for-2 and 1-for-6. Earlier, postponement of Q2 2025 earnings on August 12, 2025 coincided with a 25% drop. Today’s expansion of Nova Ortho and Spine’s footprint builds on that backdrop of growth amid financial pressure.

Market Pulse Summary

This announcement highlighted Nova Ortho and Spine’s first procedures at Doctor's Memorial Hospital,...

Analysis

This announcement highlighted Nova Ortho and Spine’s first procedures at Doctor's Memorial Hospital, expanding services into a severely underserved region of Florida. In context, Cardiff Lexington recently reported Q3 2025 revenue of $3,058,740 but a net loss of $1,144,299 and cash of only $232,033, while also securing authority for a reverse split between 1-for-2 and 1-for-6. Investors may watch how new sites translate into revenue, receivable collections at a 42% realization rate, and any balance-sheet changes.

Key Terms

orthopedics, spine care, pain management, orthopedic, +1 more

5 terms

orthopedics medical

"expertise in Orthopedics, Spine Care, and Pain Management"

Orthopedics is the medical specialty focused on diagnosing, treating and preventing problems of the musculoskeletal system — bones, joints, muscles, ligaments and tendons — including surgical repairs and implants. Investors watch orthopedics because demand for joint replacements, trauma devices and spine treatments tends to be steady and tied to aging populations, technology advances and reimbursement rules, making it a predictable revenue area sensitive to regulation, innovation and hospital spending.

spine care medical

"expertise in Orthopedics, Spine Care, and Pain Management"

Spine care covers the medical treatments, devices and services used to prevent, diagnose and treat problems of the backbone and nearby nerves — including physical therapy, injections, implants, surgeries and rehabilitation. Investors pay attention because spine care is a large, steady market driven by aging populations, chronic pain and technological advances; like servicing a car’s suspension, demand and reimbursement rules determine revenues and the value of companies that make implants, instruments or run treatment centers.

pain management medical

"leading pain management and orthopedic and spinal surgical procedures"

Pain management is the medical practice of diagnosing, treating, and reducing acute or chronic pain using medicines, therapies, devices, or procedures to help people function and feel better. It matters to investors because the effectiveness, safety, regulatory approval, insurance coverage, and patient preference for these solutions determine market size, sales potential and legal risk — like backing a better tool that helps people get back to work and daily life.

orthopedic medical

"leading pain management and orthopedic and spinal surgical procedures"

Relating to the prevention, diagnosis and treatment of injuries and disorders of the bones, joints, muscles, tendons and ligaments; commonly associated with surgeries, implants (like joint replacements or screws), braces and rehabilitation. Investors pay attention because orthopedic activity drives demand for medical devices, hospital services and rehab products—like how road repairs create business for construction firms—so changes in procedure volumes, new implant approvals or shifts in care settings can affect revenues and growth prospects for companies in this sector.

spinal surgical procedures medical

"orthopedic and spinal surgical procedures to Taylor County"

Spinal surgical procedures are medical operations on the backbone and surrounding nerves to relieve pain, correct deformities, stabilize vertebrae, or repair damage. For investors, these procedures represent demand for hospitals, surgeons, implants and devices, and ongoing revenue streams akin to maintenance work on critical infrastructure — they drive sales, shape reimbursement and regulatory risk, and influence market size for medical device and healthcare service companies.

AI-generated analysis. Not financial advice.

LEXINGTON, KY / ACCESS Newswire / December 11, 2025 / Cardiff Lexington Corporation (OTCQB:CDIX), a healthcare holding company with deep leadership and operational expertise in Orthopedics, Spine Care, and Pain Management, today announced that the Company's subsidiary, Nova Ortho and Spine, performed its first procedures at Doctor's Memorial Hospital in Perry, Florida, demonstrating Cardiff Lexington's ongoing commitment to providing best-in-class healthcare to severely underserved and rural patient populations throughout the state of Florida.

Doctor's Memorial Hospital is located in Taylor County, which according to health outcomes data, ranks among the lowest counties in Florida in terms of health factors and outcomes. Taylor County is significantly underserved with a very high healthcare provider to patient ratio while the frequency of certain procedures and treatments is higher than the Florida state average. Moreover, community feedback has identified an overwhelming need for more healthcare providers including specialty physicians.

"Our presence at Doctor's Memorial Hospital reinforces our commitment to providing best-in-class, accessible healthcare to the underserved and more rural areas around Florida," Alex Cunningham, CEO of Cardiff Lexington, commented. "This region has struggled to provide effective medical care to its patients, so when Doctor's Memorial Hospital reached out to Nova Ortho and Spine, we quickly mobilized to bring our leading pain management and orthopedic and spinal surgical procedures to Taylor County. We're very pleased to be providing critical medical care for these patients and look forward to expanding our footprint into additional areas where we can further enhance healthcare standards and practices."

Dr. Marc Brodsky, Medical Administration Director of Nova Ortho and Spine, commented, "Nova Ortho and Spine is committed to providing the very best in healthcare, and we're energized by the opportunity to be partnering with Doctor's Memorial Hospital to offer our services to a severely undeserved population. Establishing a presence in Taylor County is a logical next step in Nova Ortho and Spine's growth."

Dr. Kevin Fitzgerald, Managing Medical Director of Nova Ortho, and Spine, commented, "Nova Ortho and Spine has a very strong reputation as a provider of exceptional pain management, orthopedic, and spine care services, and we're pleased to be bringing those operational capabilities, as well as our expertise and experience to the patients of Doctor's Memorial Hospital."

About Cardiff Lexington Corporation

Cardiff Lexington Corporation (OTCQB:CDIX) is a targeted healthcare holding company dedicated to acquiring and building middle-market niche health care clinics, primarily in Orthopedics, Spine Care, and Pain Management. The Company's partnership-driven culture emphasizes service excellence, teamwork, accountability, and performance.

All current revenue is derived from Nova Ortho and Spine, LLC, which operates a network of regional specialty and ancillary orthopedic care centers across Florida and Georgia. These facilities provide traumatic injury patients with comprehensive diagnostic and surgical services, primary care evaluations, interventional pain management, and specialty consultations.

For more information on Cardiff Lexington Corporation, you may access the company's website at https://cardifflexington.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections and involve risks and uncertainties that could cause actual results to differ materially. Cardiff Lexington Corporation undertakes no obligation to update or revise forward-looking statements except as required by law.

Investor Contact

Cardiff Lexington Investor Relations
investorsrelations@cardifflexington.com
(800) 628-2100 ext. 705

or

IMS Investor Relations
cardifflexington@imsinvestorrelations.com
(203) 972-9200

SOURCE: Cardiff Lexington Corporation

View the original press release on ACCESS Newswire

FAQ

What did Cardiff Lexington (CDIX) announce on December 11, 2025?

Cardiff Lexington said subsidiary Nova Ortho and Spine performed its first procedures at Doctor's Memorial Hospital in Perry, Florida on December 11, 2025.

Which hospital did Nova Ortho and Spine start procedures at under CDIX?

Nova Ortho and Spine began procedures at Doctor's Memorial Hospital in Perry, located in Taylor County, Florida.

What services did Nova Ortho and Spine provide at Doctor's Memorial Hospital for CDIX?

The company provided pain management, orthopedic, and spine surgical procedures to local patients.

Why is Taylor County important in Cardiff Lexington's (CDIX) announcement?

Taylor County is described as severely underserved with low health outcomes and a high healthcare provider-to-patient ratio.

Did Cardiff Lexington indicate plans beyond the Perry, Florida procedures?

Yes; the company said it looks forward to expanding its footprint into additional rural Florida areas to enhance healthcare access.

Who from Cardiff Lexington commented on the Perry, Florida procedures for CDIX?

CEO Alex Cunningham and Nova Ortho and Spine leaders Dr. Marc Brodsky and Dr. Kevin Fitzgerald provided statements about the new procedures and community commitment.